ReviewFrontiers in immunology2018

Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.

Peter Bannas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.